Brain Scientific Inc
OTC:BRSF
Brain Scientific Inc
OTC:BRSF
Price:
0.0003
USD
Market Closed
Market Cap:
$372
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Brain Scientific Inc
OTC:BRSF
|
US |
|
M
|
Mabpharm Ltd
HKEX:2181
|
CN |
|
G
|
Gielda Papierow Wartosciowych w Warszawie SA
WSE:GPW
|
PL |
|
S
|
SPEL Semiconductor Ltd
BSE:517166
|
IN |
Balance Sheet
Balance Sheet Decomposition
Brain Scientific Inc
Brain Scientific Inc
Balance Sheet Decomposition is not available for
Brain Scientific Inc
Brain Scientific Inc
Balance Sheet
Brain Scientific Inc
Brain Scientific Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
10
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+61%
|
0
+52%
|
13
+2 941%
|
12
-12%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
2
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
5
|
4
|
7
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
N/A
|
0
+113%
|
0
+35%
|
1
+417%
|
5
+340%
|
14
+169%
|
7
-47%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
3
|
4
|
8
|
22
|
35
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
3
|
3
|
3
|
22
|
39
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
-113%
|
0
+71%
|
1
-1 700%
|
5
-433%
|
1
+86%
|
4
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+61%
|
0
+52%
|
13
+2 941%
|
12
-12%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
